Indraprastha Medical Corporation Ltd
BSE:532150

Watchlist Manager
Indraprastha Medical Corporation Ltd Logo
Indraprastha Medical Corporation Ltd
BSE:532150
Watchlist
Price: 402.25 INR 0.02% Market Closed
Market Cap: ₹36.9B

Wall St Price Targets

INDRAMEDCO Price Targets Summary
Indraprastha Medical Corporation Ltd

Wall Street analysts forecast INDRAMEDCO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INDRAMEDCO is 642.36 INR with a low forecast of 636.06 INR and a high forecast of 661.25 INR.

Lowest Forecast
Price Target
636.06 INR
58% Upside
Average Forecast
Price Target
642.36 INR
60% Upside
Highest Forecast
Price Target
661.25 INR
64% Upside
Indraprastha Medical Corporation Ltd Competitors:
Price Targets
NTHI
NeOnc Technologies Holdings Inc
246% Upside

Revenue
Forecast

8% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
8% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 9%.

Gross Profit
Forecast

8% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
8% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Indraprastha Medical Corporation Ltd

Operating Income
Forecast

12% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-25%
Average Miss
12% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-25%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 3 years is 24%.

Pre-Tax Income
Forecast

14% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
14% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Indraprastha Medical Corporation Ltd

Net Income
Forecast

15% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
15% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 3 years is 11%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is INDRAMEDCO's stock price target?
Price Target
642.36 INR

According to Wall Street analysts, the average 1-year price target for INDRAMEDCO is 642.36 INR with a low forecast of 636.06 INR and a high forecast of 661.25 INR.

What is the Revenue forecast for Indraprastha Medical Corporation Ltd?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 9%.

What is the Operating Income forecast for Indraprastha Medical Corporation Ltd?
Projected CAGR
24%

Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 3 years is 24%.

What is the Net Income forecast for Indraprastha Medical Corporation Ltd?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 3 years is 11%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett